Arcturus Therapeutics

PriceArcturus Therapeutics

ARCT

Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the research and development segment of medical applications for nucleic acid-focused technology. The company's product pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU and LUNAR-COV19.

Historical stock price chart and annual return over the past years

11%

5 years

% Total

ARCT
2%

5 years

Annual Return

ARCT